Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Contact information


thomas.holmes@oncology.ox.ac.uk


01865 227198

Thomas Holmes

Trial Manager - Oncology Clinical Trials Office (OCTO)

Trials worked on:

Trials currently working on: 

NuTide301: A two-part, Phase 1 open-label dose escalation and expansion study to assess safety, pharmacokinetics and clinical activity of NUC-3373, a nucleotide analogue, in participants with advanced solid tumours. 

Trials previously worked on:

SCALOP-2: A multi-centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer

CAMELLIA: A Phase I dose escalation trial of the Humanized Anti-CD47 Monoclonal Antibody Hu5F9-G4 in Haematological Malignancies

SCOT: Short Course Oncology Treatment - A study of adjuvant chemotherapy in colorectal cancer by the  CACTUS and OCTO groups.